Sage Therapeutics to Present at Society for Neuroscience 2016 An
CAMBRIDGE, Mass. –(BUSINESS WIRE) Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced upcoming presentations at the Society for Neuroscience (SFN) 2016 Annual Meeting, taking place November 12-16, 2016 in San Diego, CA. Below is the schedule for the presentations: Date: Saturday, November 12, 2016Poster Presentation Time: 1:00 p.m. – 5:00 p.m. PTLocation: Halls B-H, San Diego Convention CenterPoster Number: 34.04 / E6Title: Pharmacology of the human e subunit from the GABAA receptors Date: Monday, November 14, 2016Poster Presentation Time: 1:00 p.m. – 4:00 p.m. PTLocation: Halls B-H, San Diego Convention CenterPoster Number: 407.11 / K17Title: Neuroactive steroids exhibit synergistic interactions with barbiturates at the GABAA receptor in vitro and this impacts on activity in an animal model of seizure Date: Tuesday,…
Link to Full Article: Sage Therapeutics to Present at Society for Neuroscience 2016 An
Sharing
